MURAE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Murae Organisor Says Brijeshkumar Vaghasiya Resigns As CFO
Feb 20 (Reuters) - Murae Organisor Ltd MURO.BO:
MURAE ORGANISOR LTD - BRIJESHKUMAR VAGHASIYA RESIGNS AS CFO
Source text: ID:nBSE8xh8T4
Further company coverage: MURO.BO
(([email protected];))
Feb 20 (Reuters) - Murae Organisor Ltd MURO.BO:
MURAE ORGANISOR LTD - BRIJESHKUMAR VAGHASIYA RESIGNS AS CFO
Source text: ID:nBSE8xh8T4
Further company coverage: MURO.BO
(([email protected];))
Murae Organisor To Consider Issue Bonus Equity Shares
Feb 7 (Reuters) - Murae Organisor Ltd MURO.BO:
TO CONSIDER ISSUE BONUS EQUITY SHARES
TO CONSIDER SUB-DIVISION OF EQUITY SHARES
Source text: ID:nBSE1dmBb2
Further company coverage: MURO.BO
(([email protected];;))
Feb 7 (Reuters) - Murae Organisor Ltd MURO.BO:
TO CONSIDER ISSUE BONUS EQUITY SHARES
TO CONSIDER SUB-DIVISION OF EQUITY SHARES
Source text: ID:nBSE1dmBb2
Further company coverage: MURO.BO
(([email protected];;))
Murae Organisor To Issue Shares Worth Upto 464.7 Million Rupees
Dec 13 (Reuters) - Murae Organisor Ltd MURO.BO:
MURAE ORGANISOR LTD - TO ISSUE SHARES WORTH UPTO 464.7 MILLION RUPEES
Source text: ID:nBSE5yRt72
Further company coverage: MURO.BO
(([email protected];))
Dec 13 (Reuters) - Murae Organisor Ltd MURO.BO:
MURAE ORGANISOR LTD - TO ISSUE SHARES WORTH UPTO 464.7 MILLION RUPEES
Source text: ID:nBSE5yRt72
Further company coverage: MURO.BO
(([email protected];))
Murae Organisor To Consider Rights Issue Of Shares
Oct 10 (Reuters) - Murae Organisor Ltd MURO.BO:
MURAE ORGANISOR- TO CONSIDER RIGHTS ISSUE OF SHARES
Source text for Eikon: ID:nBSE4frFr7
Further company coverage: MURO.BO
(([email protected];))
Oct 10 (Reuters) - Murae Organisor Ltd MURO.BO:
MURAE ORGANISOR- TO CONSIDER RIGHTS ISSUE OF SHARES
Source text for Eikon: ID:nBSE4frFr7
Further company coverage: MURO.BO
(([email protected];))
Earum Pharmaceuticals Names Vaghasiya Brijeshkumar Mathurbhai As CFO
Feb 9 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
EARUM PHARMACEUTICALS LTD - NAMES VAGHASIYA BRIJESHKUMAR MATHURBHAI AS CFO
Source text for Eikon: ID:nBSESyMlS
Further company coverage: EARU.BO
(([email protected];))
Feb 9 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
EARUM PHARMACEUTICALS LTD - NAMES VAGHASIYA BRIJESHKUMAR MATHURBHAI AS CFO
Source text for Eikon: ID:nBSESyMlS
Further company coverage: EARU.BO
(([email protected];))
Earum Pharmaceuticals To Raise Up To 990 Million Rupees
Jan 30 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPROVED RAISING OF FUNDS UP TO 990 MILLION RUPEES
RAISING OF FUNDS BY WAY OF ISSUE OF WARRANTS THROUGH PREFERENTIAL ALLOTMENT
Source text for Eikon: ID:nBSE8vvhcc
Further company coverage: EARU.BO
(([email protected];))
Jan 30 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPROVED RAISING OF FUNDS UP TO 990 MILLION RUPEES
RAISING OF FUNDS BY WAY OF ISSUE OF WARRANTS THROUGH PREFERENTIAL ALLOTMENT
Source text for Eikon: ID:nBSE8vvhcc
Further company coverage: EARU.BO
(([email protected];))
Earum Pharmaceuticals Says Vijaykumar Patel Resigns As MD
Jan 19 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
VIJAYKUMAR PATEL RESIGNS AS MD
Further company coverage: EARU.BO
(([email protected];))
Jan 19 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
VIJAYKUMAR PATEL RESIGNS AS MD
Further company coverage: EARU.BO
(([email protected];))
Earum Pharmaceuticals To Consider Raising Of Funds By Way Of Issue Of Warrants
Jan 17 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
TO CONSIDER RAISING OF FUNDS BY WAY OF ISSUE OF WARRANTS
Source text for Eikon: ID:nBSEbqcVDZ
Further company coverage: EARU.BO
(([email protected];))
Jan 17 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
TO CONSIDER RAISING OF FUNDS BY WAY OF ISSUE OF WARRANTS
Source text for Eikon: ID:nBSEbqcVDZ
Further company coverage: EARU.BO
(([email protected];))
Earum Pharmaceuticals Appoints Tilva Manthan As MD
Jan 5 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPOINTMENT OF TILVA MANTHAN AS MD OF COMPANY
Source text for Eikon: ID:nBSE2FTjmC
Further company coverage: EARU.BO
(([email protected];))
Jan 5 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPOINTMENT OF TILVA MANTHAN AS MD OF COMPANY
Source text for Eikon: ID:nBSE2FTjmC
Further company coverage: EARU.BO
(([email protected];))
Earum Pharmaceuticals Approved Change In Designation Of Vijaykumar Patel To MD
Aug 14 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPROVED CHANGE IN DESIGNATION OF VIJAYKUMAR PATEL TO MD
NAMES SUNILKUMAR PATEL AS CFO
Source text for Eikon: ID:nBSE2vvSw
Further company coverage: EARU.BO
(([email protected];;))
Aug 14 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPROVED CHANGE IN DESIGNATION OF VIJAYKUMAR PATEL TO MD
NAMES SUNILKUMAR PATEL AS CFO
Source text for Eikon: ID:nBSE2vvSw
Further company coverage: EARU.BO
(([email protected];;))
Earum Pharmaceuticals Says Payal Patel Resigns As CFO
Aug 9 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
EARUM PHARMACEUTICALS LTD - PAYAL PATEL RESIGNS AS CFO
Source text for Eikon: ID:nBSEDvQ6F
Further company coverage: EARU.BO
(([email protected];))
Aug 9 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
EARUM PHARMACEUTICALS LTD - PAYAL PATEL RESIGNS AS CFO
Source text for Eikon: ID:nBSEDvQ6F
Further company coverage: EARU.BO
(([email protected];))
Earum Pharmaceuticals Approved Sub-Division Of Equity Shares Of Co
July 21 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPROVED SUB-DIVISION OF EQUITY SHARES OF CO FROM FACE VALUE OF 2 RUPEES EACH TO FACE VALUE OF 1 RUPEE EACH
TO CONSIDER PROPOSAL OF ISSUE OF BONUS EQUITY SHARES
Source text for Eikon: ID:nBSE4jBSs4
Further company coverage: EARU.BO
(([email protected];))
July 21 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPROVED SUB-DIVISION OF EQUITY SHARES OF CO FROM FACE VALUE OF 2 RUPEES EACH TO FACE VALUE OF 1 RUPEE EACH
TO CONSIDER PROPOSAL OF ISSUE OF BONUS EQUITY SHARES
Source text for Eikon: ID:nBSE4jBSs4
Further company coverage: EARU.BO
(([email protected];))
Earum Pharmaceuticals To Consider Buyback Of Equity Shares Of Company
June 27 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
EARUM PHARMACEUTICALS LTD - TO CONSIDER PROPOSAL FOR BUYBACK OF EQUITY SHARES OF COMPANY
EARUM PHARMACEUTICALS LTD -TO CONSIDER PROPOSAL OF ISSUE OF BONUS EQUITY SHARES
EARUM PHARMACEUTICALS LTD - TO CONSIDER PROPOSAL OF SUB-DIVISION OF EQUITY SHARES
Source text for Eikon: ID:nBSE1vWYfs
Further company coverage: EARU.BO
(([email protected];))
June 27 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
EARUM PHARMACEUTICALS LTD - TO CONSIDER PROPOSAL FOR BUYBACK OF EQUITY SHARES OF COMPANY
EARUM PHARMACEUTICALS LTD -TO CONSIDER PROPOSAL OF ISSUE OF BONUS EQUITY SHARES
EARUM PHARMACEUTICALS LTD - TO CONSIDER PROPOSAL OF SUB-DIVISION OF EQUITY SHARES
Source text for Eikon: ID:nBSE1vWYfs
Further company coverage: EARU.BO
(([email protected];))
Earum Pharmaceuticals Approves Proposal For Opening Of Three Overseas Branch At Dubai, Nigeria And Kenya
June 26 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPROVED PROPOSAL FOR OPENING OF THREE OVERSEAS BRANCH AT DUBAI, NIGERIA AND KENYA
Source text for Eikon: ID:nBSE7jF386
Further company coverage: EARU.BO
(([email protected];))
June 26 (Reuters) - Earum Pharmaceuticals Ltd EARU.BO:
APPROVED PROPOSAL FOR OPENING OF THREE OVERSEAS BRANCH AT DUBAI, NIGERIA AND KENYA
Source text for Eikon: ID:nBSE7jF386
Further company coverage: EARU.BO
(([email protected];))
Events:
Split
Rights
Rights
Split
Bonus
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Murae Organisor do?
Earum Pharmaceuticals Ltd, founded in 2012, specializes in trading pharmaceutical formulation products.
Who are the competitors of Murae Organisor?
Murae Organisor major competitors are Krebs Biochem.&Inds, Alpa Lab, Panchsheel Organics, Coral Laboratories, Kimia Biosciences, Vaidya Sane Ayur Lab, Denis Chem Lab. Market Cap of Murae Organisor is ₹208 Crs. While the median market cap of its peers are ₹198 Crs.
Is Murae Organisor financially stable compared to its competitors?
Murae Organisor seems to be less financially stable compared to its competitors. Altman Z score of Murae Organisor is 2.55 and is ranked 6 out of its 8 competitors.
Does Murae Organisor pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Murae Organisor latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Murae Organisor allocated its funds?
Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances
How strong is Murae Organisor balance sheet?
Balance sheet of Murae Organisor is moderately strong.
Is the profitablity of Murae Organisor improving?
The profit is oscillating. The profit of Murae Organisor is ₹7.52 Crs for TTM, ₹0.05 Crs for Mar 2024 and ₹1.98 Crs for Mar 2023.
Is the debt of Murae Organisor increasing or decreasing?
Yes, The net debt of Murae Organisor is increasing. Latest net debt of Murae Organisor is ₹260 Crs as of Sep-24. This is greater than Mar-24 when it was -₹23.42 Crs.
Is Murae Organisor stock expensive?
Murae Organisor is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Murae Organisor is 27.69, while 3 year average PE is 130. Also latest EV/EBITDA of Murae Organisor is 37.28 while 3yr average is 24.6.
Has the share price of Murae Organisor grown faster than its competition?
Murae Organisor has given lower returns compared to its competitors. Murae Organisor has grown at ~-15.41% over the last 3yrs while peers have grown at a median rate of 15.09%
Is the promoter bullish about Murae Organisor?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Murae Organisor?
There is Insufficient data to gauge this.